Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-16

FDA Approved: GLATOPA — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approved GLATOPA (glatiramer acetate) from Sandoz as an Original Application ANDA, a generic version of Copaxone for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATOPA (GLATIRAMER ACETATE)

Snippet

ORIG AP for GLATOPA (GLATIRAMER ACETATE)